Understanding and improving treatment for multiple myeloma
Comparative modeling of multiple myeloma across myeloma control continuuum: prevention, treatment, and disparity reduction
This study is looking at ways to better prevent and treat multiple myeloma, especially for patients in the early stages, with a focus on helping African American communities, so that everyone can have better options and support for managing this blood cancer.
Quick facts
| Grant type | U01 cooperative agreement |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Washington University NIH-funded |
| Lab location | 1 site (Saint Louis, United States) |
| Project ID | NIH-10902069 on NIH RePORTER |
What this research studies
This research focuses on multiple myeloma, a serious blood cancer, and aims to develop models that can help in understanding its prevention and treatment. By analyzing various intervention strategies, especially for patients at earlier stages of the disease, the project seeks to identify effective ways to reduce health disparities, particularly among African American populations. The research will also explore the economic impact of multiple myeloma treatments and the need for better screening and management strategies. Patients may benefit from insights that could lead to improved treatment options and policies.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals diagnosed with multiple myeloma or those at risk, particularly within the African American community.
Not a fit: Patients with other types of cancers or those who do not belong to the targeted demographic may not receive direct benefits from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective prevention and treatment strategies for multiple myeloma, ultimately improving survival rates and reducing disparities in care.
How similar studies have performed: While there has been significant research on other cancers, this approach to comparative modeling specifically for multiple myeloma is relatively novel and has not been extensively tested.
Where this research is happening
Saint Louis, United States
- Washington University — Saint Louis, United States (Active)
Researchers
- Principal investigator: Chang, Su-Hsin — Washington University
- Study coordinator: Chang, Su-Hsin
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.